SCHEMBL11274702

SCHEMBL11274702

Nc1cc(S)n(-c2ccccc2)n1

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP1A2 P05177 2/20 0.47
CYP2C19 P33261 2/20 0.47
MAPK1 P28482 1/20 0.47
SMN1; SMN2 Q16637 10/20 0.43
POLB P06746 1/20 0.42
RAB9A P51151 12/20 0.42
ALDH1A1 P00352 5/20 0.42
MEN1 O00255 4/20 0.42
KMT2A Q03164 4/20 0.42
TSHR P16473 2/20 0.42
GFER P55789 1/20 0.42
NPC1 O15118 12/20 0.40
MAPT P10636 5/20 0.40
KDM4E B2RXH2 4/20 0.40
STAT1 P42224 2/20 0.40
LMNA P02545 2/20 0.40
TP53 P04637 1/20 0.40
PKM P14618 1/20 0.40
PTGS1 P23219 1/20 0.39
L3MBTL1 Q9Y468 2/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7837159 0.79 CYP1A2 (0.66) CYP1A2CYP2C19MAPK1SMN1; SMN2POLB
SCHEMBL7010519 0.78 MAPK1 (0.48) CYP1A2CYP2C19MAPK1SMN1; SMN2POLB
SCHEMBL14814324 0.76 CYP1A2 (0.47) CYP1A2CYP2C19MAPK1SMN1; SMN2POLB
SCHEMBL3487668 0.76 MAPK1 (0.56) CYP1A2CYP2C19MAPK1SMN1; SMN2POLB
SCHEMBL11472621 0.74 RAB9A (0.62) CYP1A2CYP2C19MAPK1SMN1; SMN2RAB9A
SCHEMBL1012539 0.72 PTGS1 (0.46) CYP1A2CYP2C19MAPK1SMN1; SMN2POLB
SCHEMBL3180813 0.72 CYP1A2 (0.43) CYP1A2CYP2C19MAPK1SMN1; SMN2POLB
SCHEMBL19086924 0.72 SMN1; SMN2 (0.48) CYP1A2CYP2C19MAPK1SMN1; SMN2POLB
SCHEMBL18007651 0.69 ALDH1A1 (0.49) CYP1A2CYP2C19MAPK1SMN1; SMN2POLB
SCHEMBL14828018 0.68 RAB9A (0.59) CYP1A2CYP2C19MAPK1SMN1; SMN2RAB9A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0014263-B1 METHOD OF IMPROVING THE SOLUBILITY OF BIOLOGICALLY ACTIVE AGENTS IN WATER AND IN LOWER ALIPHATIC ALCOHOLS, AND COMPOUNDS HAVING AN IMPROVED SOLUBILITY BAYER AG (DE) 1982-05-05 EP disclosed